+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Enzyme-linked Immunosorbent Assay (Elisa) Testing Market 2021-2025

  • ID: 4994818
  • Report
  • June 2021
  • Region: Global
  • 120 Pages
  • TechNavio
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • Abcam Plc
  • Agilent Technologies Inc.
  • Becton
  • bioMérieux SA
  • Bio-Rad Laboratories Inc.
  • Dickinson and Co.
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the enzyme-linked immunosorbent assay (Elisa) testing market and it is poised to grow by $ 265.55 million during 2021-2025, decelerating at a CAGR of almost 9% during the forecast period. The report on the enzyme-linked immunosorbent assay (Elisa) testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing need for frequent diagnostic testing among the aging population and the rise in toxicology testing in the food industry.

The enzyme-linked immunosorbent assay (Elisa) testing market analysis includes the end-user segment and geographic landscape.

The enzyme-linked immunosorbent assay (Elisa) testing market is segmented as below:

By End-user
  • Hospitals and diagnostic centers
  • Research laboratories
  • Others

By Geography
  • North America
  • Europe
  • Asia
  • ROW

This study identifies the increase in chronic diseases as one of the prime reasons driving the enzyme-linked immunosorbent assay (Elisa) testing market growth during the next few years.

The report on enzyme-linked immunosorbent assay (Elisa) testing market covers the following areas:
  • Enzyme-linked immunosorbent assay (Elisa) testing market sizing
  • Enzyme-linked immunosorbent assay (Elisa) testing market forecast
  • Enzyme-linked immunosorbent assay (Elisa) testing market industry analysis

The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading enzyme-linked immunosorbent assay (Elisa) testing market vendors that include Abcam Plc, Agilent Technologies Inc., Becton, Dickinson and Co., bioMérieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, PerkinElmer Inc., QIAGEN NV, and Thermo Fisher Scientific Inc. Also, the enzyme-linked immunosorbent assay (Elisa) testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abcam Plc
  • Agilent Technologies Inc.
  • Becton
  • bioMérieux SA
  • Bio-Rad Laboratories Inc.
  • Dickinson and Co.

Executive Summary
  • Market Overview

Market Landscape
  • Market ecosystem
  • Value chain analysis

Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by End-user
  • Market segments
  • Hospitals and diagnostic centers - Market size and forecast 2020-2025
  • Research laboratories - Market size and forecast 2020-2025
  • Others - Market size and forecast 2020-2025

Customer landscape
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape
  • Vendor landscape
  • Landscape disruption

Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Abcam Plc
  • Agilent Technologies Inc.
  • bioMérieux SA
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • PerkinElmer Inc.
  • QIAGEN NV
  • Thermo Fisher Scientific Inc.

Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • End user - Market share 2020-2025 (%)
  • Comparison by End user
  • Hospitals and diagnostic centers - Market size and forecast 2020-2025 ($ million)
  • Hospitals and diagnostic centers - Year-over-year growth 2020-2025 (%)
  • Research laboratories - Market size and forecast 2020-2025 ($ million)
  • Research laboratories - Year-over-year growth 2020-2025 (%)
  • Others - Market size and forecast 2020-2025 ($ million)
  • Others - Year-over-year growth 2020-2025 (%)
  • Market opportunity by End user
  • Customer landscape
  • Market share by geography 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ million)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ million)
  • Europe - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ million)
  • Asia - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ million)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity by geography ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • Abcam Plc - Overview
  • Abcam Plc - Product and service
  • Abcam Plc - Key offerings
  • Abcam Plc - Key customers
  • Abcam Plc - Segment focus
  • Agilent Technologies Inc. - Overview
  • Agilent Technologies Inc. - Business segments
  • Agilent Technologies Inc. - Key offerings
  • Agilent Technologies Inc. - Key customers
  • Agilent Technologies Inc. - Segment focus
  • Becton, Dickinson and Co. - Overview
  • Becton, Dickinson and Co. - Business segments
  • Becton, Dickinson and Co. - Key offerings
  • Becton, Dickinson and Co. - Key customers
  • Becton, Dickinson and Co. - Segment focus
  • bioMérieux SA - Overview
  • bioMérieux SA - Business segments
  • bioMérieux SA - Key offerings
  • bioMérieux SA - Key customers
  • bioMérieux SA - Segment focus
  • Bio-Rad Laboratories Inc. - Overview
  • Bio-Rad Laboratories Inc. - Business segments
  • Bio-Rad Laboratories Inc. - Key offerings
  • Bio-Rad Laboratories Inc. - Key customers
  • Bio-Rad Laboratories Inc. - Segment focus
  • F. Hoffmann-La Roche Ltd. - Overview
  • F. Hoffmann-La Roche Ltd. - Business segments
  • F. Hoffmann-La Roche Ltd. - Key offerings
  • F. Hoffmann-La Roche Ltd. - Key customers
  • F. Hoffmann-La Roche Ltd. - Segment focus
  • Merck KGaA - Overview
  • Merck KGaA - Business segments
  • Merck KGaA - Key offerings
  • Merck KGaA - Key customers
  • Merck KGaA - Segment focus
  • PerkinElmer Inc. - Overview
  • PerkinElmer Inc. - Business segments
  • PerkinElmer Inc. - Key offerings
  • PerkinElmer Inc. - Key customers
  • PerkinElmer Inc. - Segment focus
  • QIAGEN NV - Overview
  • QIAGEN NV - Business segments
  • QIAGEN NV - Key offerings
  • QIAGEN NV - Key customers
  • QIAGEN NV - Segment focus
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Key customers
  • Thermo Fisher Scientific Inc. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abcam Plc
  • Agilent Technologies Inc.
  • Becton
  • bioMérieux SA
  • Bio-Rad Laboratories Inc.
  • Dickinson and Co.
The publisher recognizes the following companies as the key players in the global enzyme-linked immunosorbent assay (Elisa) testing market: Abcam Plc, Agilent Technologies Inc., Becton, Dickinson and Co., bioMérieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, PerkinElmer Inc., QIAGEN NV, and Thermo Fisher Scientific Inc.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is the increase in chronic diseases.`

According to the report, one of the major drivers for this market is the growing need for frequent diagnostic testing among the aging population.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abcam Plc
  • Agilent Technologies Inc.
  • Becton
  • Dickinson and Co.
  • bioMérieux SA
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • PerkinElmer Inc.
  • QIAGEN NV
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown